These results suggest that WWP1 expression is upregulated in the livers of MASLD model mice and humans through a positive feedback loop involving WWP1, SHARP1, and C/EBPβ [81]. The gene discussed is WWP1; the disease is metabolic dysfunction-associated steatotic liver disease.